These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21468046)

  • 1. Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer.
    Peeters DJ; Van den Eynden GG; van Dam PJ; Prové A; Benoy IH; van Dam PA; Vermeulen PB; Pauwels P; Peeters M; Van Laere SJ; Dirix LY
    Br J Cancer; 2011 Apr; 104(9):1472-7. PubMed ID: 21468046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.
    Peeters DJ; Brouwer A; Van den Eynden GG; Rutten A; Onstenk W; Sieuwerts AM; Van Laere SJ; Huget P; Pauwels P; Peeters M; Vermeulen PB; Dirix LY
    Cancer Lett; 2015 Jan; 356(2 Pt B):872-9. PubMed ID: 25449778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
    Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
    Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy.
    O'Toole SA; Spillane C; Huang Y; Fitzgerald MC; Ffrench B; Mohamed B; Ward M; Gallagher M; Kelly T; O'Brien C; Ruttle C; Bogdanska A; Martin C; Mullen D; Connolly E; McGarrigle SA; Kennedy J; O'Leary JJ
    Breast Cancer Res Treat; 2020 Jun; 181(3):571-580. PubMed ID: 32378053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
    Cabel L; Berger F; Cottu P; Loirat D; Rampanou A; Brain E; Cyrille S; Bourgeois H; Kiavue N; Deluche E; Ladoire S; Campone M; Pierga JY; Bidard FC
    Br J Cancer; 2021 Mar; 124(7):1207-1213. PubMed ID: 33473163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2-targeted therapy influences CTC status in metastatic breast cancer.
    Deutsch TM; Riethdorf S; Fremd C; Feisst M; Nees J; Fischer C; Hartkopf AD; Pantel K; Trumpp A; Schütz F; Schneeweiss A; Wallwiener M
    Breast Cancer Res Treat; 2020 Jul; 182(1):127-136. PubMed ID: 32436146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cell count and thrombosis in metastatic breast cancer.
    Beinse G; Berger F; Cottu P; Dujaric ME; Kriegel I; Guilhaume MN; Diéras V; Cabel L; Pierga JY; Bidard FC
    J Thromb Haemost; 2017 Oct; 15(10):1981-1988. PubMed ID: 28779538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
    Trapp E; Janni W; Schindlbeck C; Jückstock J; Andergassen U; de Gregorio A; Alunni-Fabbroni M; Tzschaschel M; Polasik A; Koch JG; Friedl TWP; Fasching PA; Haeberle L; Fehm T; Schneeweiss A; Beckmann MW; Pantel K; Mueller V; Rack B; Scholz C;
    J Natl Cancer Inst; 2019 Apr; 111(4):380-387. PubMed ID: 30312434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
    Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
    JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients.
    Liu XR; Shao B; Peng JX; Li HP; Yang YL; Kong WY; Song GH; Jiang HF; Liang X; Yan Y
    Breast; 2017 Apr; 32():119-125. PubMed ID: 28157583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.
    Giuliano M; Giordano A; Jackson S; Hess KR; De Giorgi U; Mego M; Handy BC; Ueno NT; Alvarez RH; De Laurentiis M; De Placido S; Valero V; Hortobagyi GN; Reuben JM; Cristofanilli M
    Breast Cancer Res; 2011 Jun; 13(3):R67. PubMed ID: 21699723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
    Schramm A; Schochter F; Friedl TWP; de Gregorio N; Andergassen U; Alunni-Fabbroni M; Trapp E; Jaeger B; Heinrich G; Camara O; Decker T; Ober A; Mahner S; Fehm TN; Pantel K; Fasching PA; Schneeweiss A; Janni W; Rack BK;
    Clin Breast Cancer; 2017 Jul; 17(4):279-285. PubMed ID: 28190761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.
    Liu MC; Shields PG; Warren RD; Cohen P; Wilkinson M; Ottaviano YL; Rao SB; Eng-Wong J; Seillier-Moiseiwitsch F; Noone AM; Isaacs C
    J Clin Oncol; 2009 Nov; 27(31):5153-9. PubMed ID: 19752342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer.
    Stefanovic S; Deutsch TM; Riethdorf S; Fischer C; Hartkopf A; Sinn P; Feisst M; Pantel K; Golatta M; Brucker SY; Sütterlin M; Schneeweiss A; Wallwiener M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
    Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Diéras V; Mathiot C; Mignot L; Thiery JP; Sastre-Garau X; Pierga JY
    Ann Oncol; 2008 Mar; 19(3):496-500. PubMed ID: 18187488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
    Kirwan CC; Descamps T; Castle J
    Clin Transl Oncol; 2020 Jun; 22(6):870-877. PubMed ID: 31473984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.
    Wallwiener M; Hartkopf AD; Riethdorf S; Nees J; Sprick MR; Schönfisch B; Taran FA; Heil J; Sohn C; Pantel K; Trumpp A; Schneeweiss A
    BMC Cancer; 2015 May; 15():403. PubMed ID: 25972110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.